Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Forest Laboratories
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
History of symptomatic atrial fibrillation that significantly disrupts the patient's customary daily living activities
History of congestive heart failure and/or ischemic heart disease
Sinus rhythm (normal heart rhythm) upon entry to the 30 day screening period for the study
At least one episode of symptomatic atrial fibrillation during the screening period, with a spontaneous return to sinus rhythm.
Sinus rhythm immediately prior to dosing
You may not be if
Previously unsuccessful cardioversions within 60 days of screening period
Failed to respond to any Class III antiarrhythmic drugs
Qualifying arrhythmia due to acute reversible illness, acute myocardial infarction, and/or cardiac or thoracic surgery within one month prior to randomization
Previously in an azimilide study
Clareo Health | Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.
